Humira, a new biologic therapy for rheumatoid arthritis

January 2005

Health Canada has approved Humira, a new biologic therapy for rheumatoid arthritis.

Humira (adalimumab) works similar to Remicade (infliximab) and Enbrel (etanercept). These block tumor necrosis factor alpha, or TNF-alpha.

People with rheumatoid arthritis have too much TNF-alpha that attacks bones, cartilage, and joints...leading to inflammation.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote